Paris-based Biolevate raises €30 million Series A to scale AI platform for life-sciences workflows
Biolevate, a Paris‑based AI startup for life‑sciences, closed a €30 million Series A led jointly by RAISE France and Orange Ventures, with participation from MSD Global Health Innovation Fund, Station F and EQT Ventures. The funding will fuel product scaling, US expansion, and further AI integration in regulatory and drug‑development workflows.